EVRYSDI
Active substance: risdiplam
POWDER, FOR SOLUTION · RISDIPLAM .75 mg/mL
United StatesActive
Marketing holder: Genentech, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- RISDIPLAM · .75 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 10 |
|
| EU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-9e09-7daf-8060-85f10fd19a36,01a120c3-b062-75a1-bad4-c3c6b4c96fc0,01a120c3-ce29-7db4-9fc3-0043b2f062de,01a120c3-d148-7be0-baf3-1f9345785640,01a120c3-de5d-727c-b9a8-bb4cf3e7c6da;count=10 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-6015-7491-ae4e-e353331fa50b,01a12093-93c3-7574-aa8e-c2b175669835;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50242-175
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 50242-175 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50242-175 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50242-175 · Verified 2026-10-09 · open in source